相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-Blind Study of 102 Postmenopausal Women With Distal Radial Fractures
Per Aspenberg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling
Chuwen Lin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats
K. Wermelin et al.
BONE (2008)
Osteocyte-derived sclerostin inhibits bone formation:: Its role in bone morphogenetic protein and Wnt signaling
Peter ten Dijke et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bone remodeling during fracture repair: The cellular picture
Aaron Schindeler et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Local peroperative treatment with a bisphosphonate improves the fixation of total knee prostheses - A randomized, double-blind radiostereometric study of 50 patients
Maria Hilding et al.
ACTA ORTHOPAEDICA (2007)
Beta-catenin signaling plays a disparate role in different phases of fracture repair: Implications for therapy to improve bone healing
Yan Chen et al.
PLOS MEDICINE (2007)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
RL Bezooijen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Systemic and local ibandronate enhance screw fixation
B Skoglund et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2004)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Implant fixation enhanced by intermittent treatment with parathyroid hormone
R Skripitz et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)